BNY Mellon Bond M holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
BNY Mellon Bond Fund Class M MPBFX
- NAV / 1-Day Return 10.98 / +0.55 %
- Total Assets 1.2B
-
Adj. Expense Ratio
0.580%
- Expense Ratio 0.580%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Intermediate Core Bond
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Min. Initial Investment 10,000
- Status Open
- TTM Yield 3.85%
- Effective Duration 6.10 years
USD | NAV as of Jun 12, 2026 | 1-Day Return as of Jun 12, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MPBFX
Will MPBFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MPBFX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MPBFX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
United States Treasury Bonds 4.625% | 2.80 | 33M | Government |
United States Treasury Notes 3.5% | 2.52 | 29M | Government |
United States Treasury Notes 3.625% | 2.11 | 25M | Government |
United States Treasury Notes 3.875% | 1.94 | 23M | Government |
United States Treasury Notes 3.625% | 1.85 | 22M | Government |
United States Treasury Notes 4.375% | 1.70 | 20M | Government |
United States Treasury Bonds 4.75% | 1.63 | 19M | Government |
United States Treasury Notes 4.25% | 1.62 | 19M | Government |
United States Treasury Notes 3.25% | 1.47 | 17M | Government |
United States Treasury Notes 4% | 1.42 | 17M | Government |